BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Verastem, Inc. Reports on Ongoing Trials at Cancer Advance at Harvard Medical School

  September 20, 2013

   · 

  1 min read
• FDA

  GlaxoSmithKline, Theravance, Inc.'s RELVAR™ ELLIPTA™Gains Approval in Japan for the Treatment of Asthma

  September 20, 2013

   · 

  12 min read
• BioIndustry Association: Two UK Companies Shortlisted for EuropaBio Most Innovative EU Biotech SME Award

  September 20, 2013

   · 

  3 min read
• BioCapital

  CEL-SCI Announces 1-for-10 Reverse Stock Split

  September 20, 2013

   · 

  1 min read
• GHX Encourages Healthcare Manufacturers to Take a Holistic, Strategic Approach to UDI in the Wake of the U.S. FDA’s Final Ruling

  September 20, 2013

   · 

  1 min read
• Skyepharma PLC: Capital Markets Day, Muttenz, Switzerland

  September 20, 2013

   · 

  3 min read
• More Fall Concerns for Large Imaging Systems as Philips Healthcare Issues Warning

  September 20, 2013

   · 

  1 min read
• Deals

  BASF Pays About $51.2 Million for Verenium Corporation; Verenium Stock Rises +58.17% at Market Close (September 20, 2013)

  September 20, 2013

   · 

  4 min read
• Business

  GlaxoSmithKline Inks $196 Million Biomedical Advanced Research and Development Authority (BARDA) U.S. Anthrax Treatment Deal

  September 20, 2013

   · 

  1 min read
• Deals

  Valeant Pharmaceuticals International Buys Its Way to the Top

  September 20, 2013

   · 

  1 min read